No Data
No Data
KidsWell Bio: Confirmation Document.
KidsWell Bio: Correction of Securities Report - 23rd Fiscal Year (April 1, 2022 - March 31, 2023)
KIDSWELL BIO: Notice regarding publication of consolidated earnings forecasts due to the transition to consolidated financial results
KIDSWELL BIO: Financial Results Report for the Fiscal Year Ending March 31, 2024 Supplemental Explanatory Material
KIDSWELL BIO: Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (unconsolidated)
Kidswell Bio FY Parent Loss Y1.42B Vs Loss Y657.00M
Kidswell Bio Corp. (4584.TO) Japan Year Ended March 31 PARENT 2024 2023 Revenue Y2.43 bln Y2.78 bln Operating Profit (Y1.34 bln) (Y5
No Data